- Home
- EXTR vs IRON Comparison
EXTR vs IRON Comparison
Compare EXTR & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXTR
- IRON
- Stock Information
- Founded
- EXTR 1996
- IRON 2017
- Country
- EXTR United States
- IRON United States
- Employees
- EXTR N/A
- IRON N/A
- Industry
- EXTR Telecommunications Equipment
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- EXTR Telecommunications
- IRON Health Care
- Exchange
- EXTR Nasdaq
- IRON Nasdaq
- Market Cap
- EXTR 1.8B
- IRON 1.4B
- IPO Year
- EXTR 1999
- IRON N/A
- Fundamental
- Price
- EXTR $14.80
- IRON $44.24
- Analyst Decision
- EXTR Strong Buy
- IRON Strong Buy
- Analyst Count
- EXTR 7
- IRON 10
- Target Price
- EXTR $18.29
- IRON $83.80
- AVG Volume (30 Days)
- EXTR 1.6M
- IRON 397.9K
- Earning Date
- EXTR 04-30-2025
- IRON 05-07-2025
- Dividend Yield
- EXTR N/A
- IRON N/A
- EPS Growth
- EXTR N/A
- IRON N/A
- EPS
- EXTR N/A
- IRON N/A
- Revenue
- EXTR $1,089,717,000.00
- IRON N/A
- Revenue This Year
- EXTR $3.03
- IRON N/A
- Revenue Next Year
- EXTR $8.34
- IRON N/A
- P/E Ratio
- EXTR N/A
- IRON N/A
- Revenue Growth
- EXTR N/A
- IRON N/A
- 52 Week Low
- EXTR $10.10
- IRON $28.25
- 52 Week High
- EXTR $19.24
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- EXTR 67.86
- IRON 45.99
- Support Level
- EXTR $13.64
- IRON $40.36
- Resistance Level
- EXTR $15.03
- IRON $47.21
- Average True Range (ATR)
- EXTR 0.51
- IRON 2.87
- MACD
- EXTR 0.35
- IRON 0.10
- Stochastic Oscillator
- EXTR 94.01
- IRON 37.67
About EXTR Extreme Networks Inc.
Extreme Networks Inc provides cloud networking solutions and industry services and support. Extreme designs, develops, and manufactures wired, wireless, and software-defined wide area-network (SD- WAN) infrastructure equipment, software and cloud-based network management solutions. The company's cloud solution is a single platform that offers unified network management of wireless access points, switches, and SD-WAN. The company operates in a single segment which develops and markets network infrastructure equipment. Roughly half of the firm's revenue is generated in the Americas, with the rest coming from Europe, the Middle East, Africa, and Asia-Pacific.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.